400mg Bevacizumab Injection

Name: 400mg Bevacizumab Injection
Brand: GLOBMED INDIA

Get a Price/Quote

MOQ : 10 Vials

400mg Bevacizumab Injection Specification

Salt Composition
Bevacizumab 400mg/16ml

Indication
Cancer Therapy (Colorectal Cancer, Lung Cancer, Glioblastoma, etc.)

Dosage Form
Injection

Feature
Monoclonal Antibody

Ingredients
Bevacizumab, Excipients

Application
Intravenous Infusion

Ph Level
6.2

Physical Color/Texture
Clear to slightly opalescent, colorless to pale brown liquid

Storage Instructions
Store at 2C to 8C. Do not freeze.

Shelf Life
24 months

Brand Name
KRABEVA

Therapeutic Class
Anticancer agent

Packing Size
400 mg/16 ml per vial

Container Type
Glass Vial

Common Side Effects
Hypertension, proteinuria, hemorrhage, thrombosis, GI perforation

Preservative Free
Yes

Administration Route
Intravenous

Sterility
Sterile solution

Prescription
Prescription Only

Preparation
Ready to dilute and infuse

400mg Bevacizumab Injection Trade Information

Minimum Order Quantity
10 Vials

Payment Terms
Cash in Advance (CID)

Supply Ability
500 Vials Per Month

Delivery Time
2-5 Days

Main Export Market(s)
Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

Main Domestic Market
All India

400mg Bevacizumab Injection About

Procure the splendiferous KRABEVA 400mg Bevacizumab Injection-your majestic solution for advanced cancer therapy. Presented in a sterile glass vial (400mg/16ml), this ready-to-dilute and infuse, preservative-free formulation ensures superior efficacy as a monoclonal antibody against colorectal, lung, and glioblastoma cancers. Prepared with strict adherence to sterility, this product is for intravenous use only, under prescription. Benefit from the hot deal with best price offers, exclusive for exporters, suppliers, and traders in India. Secure your therapeutic advantage with our premium anticancer agent-KRABEVA.

Outstanding Features & Application Areas

KRABEVA 400mg Bevacizumab Injection boasts a sterile, preservative-free solution with a pH of 6.2, making it splendiferous for hospital oncology settings. Designed for intravenous infusion, it comes in a clear to slightly opalescent, colorless to pale brown liquid, ready to dilute-ensuring convenience and adaptability. Its primary area of application encompasses a wide spectrum of cancers, including colorectal cancer, lung cancer, and glioblastoma. The superior glass vial container maintains stability throughout its 24-month shelf life.

Certifications, Export Markets & Sample Availability

KRABEVA 400mg Bevacizumab Injection adheres to majestic quality certifications necessary for global export. It is actively supplied to various main export markets and is supported by robust logistics to ensure products are safely handed over to international clients. Prospective buyers may request product samples, and the best asking price is available upon inquiry. Efficient processes ensure timely delivery and secure procurement, making KRABEVA the preferred option for global suppliers and traders.

FAQ's of 400mg Bevacizumab Injection:

Q: How should KRABEVA 400mg Bevacizumab Injection be stored before use?

A: KRABEVA must be stored at temperatures between 2C and 8C and should never be frozen. Always keep it in the original glass vial until ready for use.

Q: What is the recommended route and process for administering KRABEVA 400mg Injection?

A: The injection is for intravenous infusion only and should be prepared by diluting the sterile solution before administration, following your healthcare provider's guidelines.

Q: When is KRABEVA 400mg typically indicated for use?

A: KRABEVA is indicated for cancer therapy, specifically for conditions like colorectal cancer, lung cancer, glioblastoma, and other relevant malignancies as prescribed by a medical professional.

Q: Where can I procure KRABEVA 400mg Bevacizumab Injection?

A: You can procure KRABEVA through authorized exporters, suppliers, or traders in India, ensuring all transactions adhere to prescription and regulatory requirements.

Q: What are the common side effects associated with KRABEVA 400mg?

A: Common side effects may include hypertension, proteinuria, hemorrhage, thrombosis, and gastrointestinal perforation. It's crucial to use this medication only under medical supervision.